Master ChatGPT Codex in 2026 with our comprehensive guide. Explore local automations, custom plugins, and memory features to ...

The smartest way to use AI may not be letting it interact with your files, but asking it to write software that handles them ...

A guardrail is a spending limit your AI enforces on its own, before a runaway bill enforces one on you. This is the move that ...

The routine work of "invoice creation" that repeats every month. How much time do you spend copying and pasting values from spreadsheets, converting them to PDF, and attaching them to emails? Those ...

Describing what you need and having the invoice appear - no templates, no dragging fields, no logging into three different tools to get paid. Invoicing has never been the hard part of freelancing. The ...

As the end of every month approached, I felt a slight sense of gloom. I would open each invoice PDF received from clients one by one and manually type the amount, issue date, and payee into a ...

Tax season is nigh upon us, and this year there is a meaningfully different option for the millions of Kenyan traders who have long found eTIMS too technical, too slow, or simply too much to deal with ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...